MAPK8 and breast carcinoma: As shown in Figure 4C, as an upstream mediator of FoxO signaling, MAPK8 was suppressed in breast cancer cells (MCF‐7, T47D, ZR‐75, and MDA‐MB‐231) and liver cells (LO2) treated with TAM.